APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease

被引:47
作者
Abdul, HM
Wenk, GL
Gramling, M
Hauss-Wegrzyniak, B
Butterfield, DA [1 ]
机构
[1] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA
[2] Univ Arizona, Dept Psychol & Neurol, Tucson, AZ 85724 USA
关键词
A beta(1-42); cholesterol; presenilin-1; amyloid precursor protein; protein carbonyl; lipid peroxidation; oxidative stress; Alzheimer's disease;
D O I
10.1016/j.neulet.2004.06.077
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epidemiological and biochemical studies strongly implicate a role for cholesterol in the pathogenesis of Alzheimer's disease (AD). Mutation in the PS-1 and APP genes, which increases production of the highly amyloidogenic amyloid beta-peptide (Abeta42), is the major cause of familial AD. The AD brain is under significant oxidative stress, including protein oxidation and lipid peroxidation. In the present study, protein oxidation and lipid peroxidation were compared in the brain homogenates from knock-in mice expressing mutant human PS-1 and APP in relation to the intake of dietary cholesterol. The APP and PS-1 mice displayed increased oxidative stress as measured by protein oxidation and lipid peroxidation, independent of dietary cholesterol. These results are discussed with reference to proposed therapeutic strategies of AD. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:148 / 150
页数:3
相关论文
共 21 条
  • [1] Avdulov NA, 1997, J NEUROCHEM, V69, P1746
  • [2] Brain cholesterol:: Long secret life behind a barrier
    Björkhem, I
    Meaney, S
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : 806 - 815
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] Butterfield D.A., 1997, ADV CELL AGING GERON, V2, P161
  • [5] BUTTERFIELD DA, 2002, FREE RADIC BIOL MED, V32
  • [6] Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1
    Duff, K
    Eckman, C
    Zehr, C
    Yu, X
    Prada, CM
    Pereztur, J
    Hutton, M
    Buee, L
    Harigaya, Y
    Yager, D
    Morgan, D
    Gordon, MN
    Holcomb, L
    Refolo, L
    Zenk, B
    Hardy, J
    Younkin, S
    [J]. NATURE, 1996, 383 (6602) : 710 - 713
  • [7] Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
    Fassbender, K
    Simons, M
    Bergmann, C
    Stroick, M
    Lütjohann, D
    Keller, P
    Runz, H
    Kühl, S
    Bertsch, T
    von Bergmannn, K
    Hennerici, M
    Beyreuther, K
    Hartmann, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) : 5856 - 5861
  • [8] Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice
    Hsiao, K
    Chapman, P
    Nilsen, S
    Eckman, C
    Harigaya, Y
    Younkin, S
    Yang, FS
    Cole, G
    [J]. SCIENCE, 1996, 274 (5284) : 99 - 102
  • [9] Statins and the risk of dementia
    Jick, H
    Zornberg, GL
    Jick, SS
    Seshadri, S
    Drachman, DA
    [J]. LANCET, 2000, 356 (9242) : 1627 - 1631
  • [10] Midlife vascular risk factors and late-life mild cognitive impairment -: A population-based study
    Kivipelto, M
    Helkala, EL
    Hänninen, T
    Laakso, MP
    Hallikainen, M
    Alhainen, K
    Soininen, H
    Tuomilehto, J
    Nissinen, A
    [J]. NEUROLOGY, 2001, 56 (12) : 1683 - 1689